Teligene Us

Business Services · California, United States · 51-200 Employees

View Company Info for Free

Overview

Headquarters

2060d E Avenida De Los Arboles 636, Thou...

Phone Number

+86 51286669213

Revenue

$14 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About Teligene Us

Suzhou TeliGene Biotechnology Co., Ltd. specializes in the design, research, and industrialization of innovative small molecule targeted drugs for cancer treatment, particularly in areas with urgent clinical needs. Founded in 2011 by Dr. Zhang Dawei, a former chief scientist at Amgen, the company leverages advanced drug development technologies and has a strong focus on creating novel candidates with unique brain permeability. Their projects are currently in various clinical trial phases, aiming to provide new therapeutic options for patients with limited treatment alternatives. The company is committed to addressing unmet medical needs and plans to launch new drug products in the coming years, contributing to global health advancements.Explore more
Teligene Us's Social MediaPopular SearchesTeligene Us LLCSuzhou Taolue Biotechnology Co LtdTeligene USWww.teligenebio.cnSIC Code 87,873NAICS Code 54,541Show more

Is Teligene Us your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Teligene Us

Compare insights from companies similar to Teligene Us, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Teligene Us

$14M
51-200
Private
-
2011
N/A
$19.1M
51-200
Public
$170.5M
2013
Eef Schimmelpennink, President & Chief Executive Officer at Lenz Therapeutics
Eef SchimmelpenninkPresident & CEO
$15.9M
11-50
Private
-
2017
SL
Susan LowVice President
$11.4M
51-200
Public
$214.6M
2016
$9.2M
51-200
Private
-
2015
<$5M
11-50
Private
$260.1M
2017
ZG
Zhenhai GaoCo-founder, President & CEO
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Teligene Us is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Teligene Us is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Teligene Us.

Teligene Us Tech Stack

A closer look at the technologies used by Teligene Us

Most Recent Scoops

Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
See more scoops

Top Business Services Companies

Frequently Asked Questions Regarding Teligene Us

What is Teligene Us's official website?
Teligene Us's official website is www.teligenebio.cn
What is Teligene Us's Revenue?
Teligene Us's revenue is $14 Million
What is Teligene Us's SIC code?
Teligene Us's SIC: 87,873
What is Teligene Us's NAICS code?
Teligene Us's NAICS: 54,541
How many employees does Teligene Us have?
Teligene Us has 51-200 employees
What industry does Teligene Us belong to?
Teligene Us is in the industry of: Business Services, Research & Development
What is Teligene Us competition?
Teligene Us top competitors include: NKT, pH Pharma, Verseau Therapeutics, Leap Therapeutics
What technology does Teligene Us use?
Some of the popular technologies that Teligene Us uses are: Google Font API, jQuery
How do I contact Teligene Us?
Teligene Us contact info: Phone number: +86 51286669213 Website: www.teligenebio.cn
What does Teligene Us do?

Suzhou TeliGene Biotechnology Co., Ltd. specializes in the design, research, and industrialization of innovative small molecule targeted drugs for cancer treatment, particularly in areas with urgent clinical needs. Founded in 2011 by Dr. Zhang Dawei, a former chief scientist at Amgen, the company leverages advanced drug development technologies and... has a strong focus on creating novel candidates with unique brain permeability. Their projects are currently in various clinical trial phases, aiming to provide new therapeutic options for patients with limited treatment alternatives. The company is committed to addressing unmet medical needs and plans to launch new drug products in the coming years, contributing to global health advancements.Read More

What are Teligene Us social media links?
Teligene Us Linkedin page
Is Teligene Us a public company?
Teligene Us is private company therefore does not currently have an official ticker symbol
See more information about Teligene Us

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.